Vildagliptin-Metformin: Is it a causative of cardiac muscle failure in Type 2 Diabetic patients?
<p>Vildagliptin is an oral anti-hyperglycaemic agent, commonly called an anti-diabetic medication that belongs to the family of medications known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is a medicine that is used to treat Type 2 Diabetes Mellitus [1]. </p>
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications,
2021-09-24.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|